Mrs
Dr
Miss
Ms
Prof
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/1496217
Endometrial Cancer Clinical Trials Review, Q4, 2010
Description:
Endometrial Cancer Clinical Trials Review, Q4, 2010
Summary
Our clinical trial report, “Endometrial Cancer Global Clinical Trials Review, Q4, 2010" provides data on the Endometrial Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Endometrial Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Endometrial Cancer).
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade
- Number of clinical trials segmented by key drugs
- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy
- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Summary
Our clinical trial report, “Endometrial Cancer Global Clinical Trials Review, Q4, 2010" provides data on the Endometrial Cancer clinical trial scenario. This report provides in-depth information and data relating to the clinical trials on Endometrial Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial development throughout the world, focusing on the status of participation by the developing nations. It offers coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides information pertaining to the number of trials for the key drugs for treating Endometrial Cancer).
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
Scope
- Data on the number of clinical trials conducted in North America, South And Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status and trial success rate
- Review of key discontinued trials (suspended, withdrawn and terminated)
- Overview of the enrollment pattern by phase for the past decade
- Number of clinical trials segmented by key drugs
- Clinical trial overview of top 20 companies, which include Pfizer Inc., AstraZeneca PLC, Eli Lilly and Company, and so on.
- Clinical trial overview of top 20 Universities / Institutes / Hospitals including National Cancer Institute, Cancer Research UK, Cancer Research Institute , and others
Reasons to buy
- Understand the dynamics of a particular indication as a whole
- Examine the performance of the trials in terms of their status, recruitment, success rates and others
- Obtain discontinued trial information for trials across the globe
- Understand the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Contents:
1
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Endometrial Cancer
2.2 Report Guidance
3 Clinical Trials by Region
4 Clinical Trials by Country
4.1.1 Top Five Countries Contributing to Clinical Trials in Asia-Pacific
4.1.2 Top Five Countries Contributing to Clinical Trials in Europe
4.1.3 Top Countries Contributing to Clinical Trials in North America
4.1.4 Top Countries Contributing to Clinical Trials in Middle East and Africa
4.1.5 Top Countries Contributing to Clinical Trials in Central and South America
4.2 Clinical Trials by BRIC Countries
5 Clinical Trials by Phase
5.1 In Progress Trials by Phase
6 Clinical Trials by Trial Status
7 Unaccomplished Trials of Endometrial Cancer
8 Subjects Recruited Over a Period of Time
9 Prominent Sponsors
9.1 Top Companies Participating in Endometrial Cancer Therapeutics Clinical Trials
10 Prominant Drug Comparison
11 Clinical Trial Profiles
11.1 Clinical Trial Overview of Top Companies
11.1.1 Eli Lilly and Company
11.1.2 GlaxoSmithKline PLC
11.1.3 Bristol-Myers Squibb Company
11.1.4 Merck & Co., Inc.
11.1.5 Novartis AG
11.1.6 Amgen Inc.
11.1.7 AstraZeneca PLC
11.1.8 Johnson & Johnson
11.1.9 Eisai Co., Ltd.
11.1.10 Endocyte, Inc.
11.1.11 EntreMed, Inc.
11.1.12 AEterna Zentaris Inc.
11.1.13 Ariad Pharmaceuticals, Inc.
11.1.14 CytoCore, Inc.
11.1.15 Exelixis, Inc.
11.1.16 Ipsen S.A.
11.1.17 Merrimack Pharmaceuticals, Inc.
11.1.18 Sanofi-Aventis
11.1.19 Xoft, Inc.
11.1.20 Zeltia, S.A.
11.2 Clinical Trial Overview of Top Institutes / Hospitals / Universities
11.2.1 National Cancer Institute (NCI)
11.2.2 The University of Texas M. D. Anderson Cancer Center
11.2.3 Case Comprehensive Cancer Center
11.2.4 Memorial Sloan Kettering Cancer Center
11.2.5 Masonic Cancer Center
11.2.6 National Taiwan University Hospital
11.2.7 Princess Margaret Hospital
11.2.8 New York University School of Medicine
11.2.9 University of New Mexico
11.2.10 University of Wisconsin Madison
11.2.11 Cancer Research UK
11.2.12 Dana-Farber Cancer Institute
11.2.13 Herbert Irving Comprehensive Cancer Center
11.2.14 Mayo Clinic
11.2.15 Ohio State University
11.2.16 Rabin Medical Center
11.2.17 Robert H. Lurie Comprehensive Cancer Center of Northwestern University
11.2.18 St George's University of London
11.2.19 The Queensland Centre for Gynaecological Cancer
11.2.20 UNC Lineberger Comprehensive Cancer Center
12 Appendix
12.1 Abbreviations
12.2 Definitions
12.3 Research Methodology
12.4 Secondary Research
12.5 About Us
12.6 Contact Us
12.7 Disclaimer
12.8 Source
1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Endometrial Cancer
2.2 Report Guidance
3 Clinical Trials by Region
4 Clinical Trials by Country
4.1.1 Top Five Countries Contributing to Clinical Trials in Asia-Pacific
4.1.2 Top Five Countries Contributing to Clinical Trials in Europe
4.1.3 Top Countries Contributing to Clinical Trials in North America
4.1.4 Top Countries Contributing to Clinical Trials in Middle East and Africa
4.1.5 Top Countries Contributing to Clinical Trials in Central and South America
4.2 Clinical Trials by BRIC Countries
5 Clinical Trials by Phase
5.1 In Progress Trials by Phase
6 Clinical Trials by Trial Status
7 Unaccomplished Trials of Endometrial Cancer
8 Subjects Recruited Over a Period of Time
9 Prominent Sponsors
9.1 Top Companies Participating in Endometrial Cancer Therapeutics Clinical Trials
10 Prominant Drug Comparison
11 Clinical Trial Profiles
11.1 Clinical Trial Overview of Top Companies
11.1.1 Eli Lilly and Company
11.1.2 GlaxoSmithKline PLC
11.1.3 Bristol-Myers Squibb Company
11.1.4 Merck & Co., Inc.
11.1.5 Novartis AG
11.1.6 Amgen Inc.
11.1.7 AstraZeneca PLC
11.1.8 Johnson & Johnson
11.1.9 Eisai Co., Ltd.
11.1.10 Endocyte, Inc.
11.1.11 EntreMed, Inc.
11.1.12 AEterna Zentaris Inc.
11.1.13 Ariad Pharmaceuticals, Inc.
11.1.14 CytoCore, Inc.
11.1.15 Exelixis, Inc.
11.1.16 Ipsen S.A.
11.1.17 Merrimack Pharmaceuticals, Inc.
11.1.18 Sanofi-Aventis
11.1.19 Xoft, Inc.
11.1.20 Zeltia, S.A.
11.2 Clinical Trial Overview of Top Institutes / Hospitals / Universities
11.2.1 National Cancer Institute (NCI)
11.2.2 The University of Texas M. D. Anderson Cancer Center
11.2.3 Case Comprehensive Cancer Center
11.2.4 Memorial Sloan Kettering Cancer Center
11.2.5 Masonic Cancer Center
11.2.6 National Taiwan University Hospital
11.2.7 Princess Margaret Hospital
11.2.8 New York University School of Medicine
11.2.9 University of New Mexico
11.2.10 University of Wisconsin Madison
11.2.11 Cancer Research UK
11.2.12 Dana-Farber Cancer Institute
11.2.13 Herbert Irving Comprehensive Cancer Center
11.2.14 Mayo Clinic
11.2.15 Ohio State University
11.2.16 Rabin Medical Center
11.2.17 Robert H. Lurie Comprehensive Cancer Center of Northwestern University
11.2.18 St George's University of London
11.2.19 The Queensland Centre for Gynaecological Cancer
11.2.20 UNC Lineberger Comprehensive Cancer Center
12 Appendix
12.1 Abbreviations
12.2 Definitions
12.3 Research Methodology
12.4 Secondary Research
12.5 About Us
12.6 Contact Us
12.7 Disclaimer
12.8 Source
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/1582661
Order by Fax - using the order form below
Order By Post - print the order form below and send to
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Page 1 of 2
Printed Sunday, May 19, 2013
3:09:47 AM
3:09:47 AM
Fax order form
To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
Product name
Endometrial Cancer Clinical Trials Review, Q4, 2010
Web Address
http://www.researchandmarkets.com/reports/1496217
Office Code
OC8DIQSSRORWWS
Report Formats
Please enter the quantity of the report format you require.
| Format | Quantity | Price | Electronic (PDF) - Enterprisewide |
|
EURO€ 2,306.00 |
|---|---|---|
| Electronic (PDF) - Site License |
|
EURO€ 1,537.00 |
| Electronic (PDF) - Single User |
|
EURO€ 769.00 |
Contact information
Please enter all the information below in block capitals.
Title:
Mr
Mrs
Dr
Miss
Ms
Prof
Mrs
Dr
Miss
Ms
Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Page 2 of 2
Printed Sunday, May 19, 2013
3:09:47 AM
3:09:47 AM
Payment information
Please indicate the payment method you would like to use by selecting the appropriate box.
Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date:
/
Card Number:
CVV Security Code:
Issue date:
/ (Diners Club only)
Pay by Check:
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
Pay by Wire Transfer:
Please transfer funds to:
Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp